Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Hereditary neoplastic syndrome
EGLN1-related erythrocytosis and pheochromocytoma/paraganglioma predisposition
Hereditary cancer predisposition due to variation(s) in the EGLN12 gene, which confers a predisposition to erythrocytosis and pheochromocytoma/paraganglioma.
This condition has no sub-types.